Drug Target Review

SEPTEMBER 22, 2023

The substantial value of organoids is becoming increasingly recognised by supportive government initiatives developing novel drugs, with a growth rate of 22 percent between 2023 and 2030 and a market size predicted to reach over US $6.5 billion by 2030.

Clinical Research 116

Clinical Research Research Drug Development Molecular Biology 116

Vial

MAY 20, 2024

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. What is a Pre-Clinical CRO? between 2024 and 2030. over this period.

Clinical Research 52

Clinical Research Clinical Trials Research Trials 52

Olympian Clinical Research

JULY 12, 2022

Major depressive disorder ( MDD ), also known as clinical depression, is characterized by a persistent feeling of sadness or emptiness lasting for at least two weeks. According to the World Health Organization, major depressive disorder is projected to rank first as the top burden of disease worldwide by 2030.

Clinical Research 94

Clinical Research Doctors Treatment Research 94

Vial

FEBRUARY 8, 2024

In recent years, however, clinical trials have become increasingly complex, adding burden to research teams and clinical research sites. Starting with describing challenges faced in managing clinical trials, we explore how CROs address challenges and how sponsors benefit from partnering with CROs. billion in 2030.

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

PPD

OCTOBER 18, 2023

Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030. There has been an unprecedented expansion of different types of pharmaceutical therapies, as well as a change in the overall approach to health care.

Laboratories 52

Laboratories Assay Development Small Molecule Drug Development 52

Vial

APRIL 18, 2024

The urgency for novel therapeutic approaches makes ophthalmology a rapidly growing domain of clinical research. Market research indicates significant growth in the ophthalmic clinical trials market, driven by increased disease prevalence, demand for ocular treatments, and rising research funding. from 2023 to 2030.

Clinical Trials 52

Clinical Trials Trials Treatment Clinical Research 52

Vial

FEBRUARY 23, 2024

In 2022, the global market value of patient portals within the clinical research and healthcare industries was estimated to be US $2.9 billion and is expected to climb at a compound annual growth rate (CAGR) of 19.44% between 2023 and 2030.

Clinical Trials 52

Clinical Trials Clinical Research Trials Hospitals 52